Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 8, Issue 5, 2001, Pages 367-371

  Takagi, Hitoshi ^a   Nagamine, T ^a   Abe, T ^a   Takayama, H ^a   Sato, K ^a   Otsuka, T ^a   Kakizaki, S ^a   Hashimoto, Y ^a   Matsumoto, T ^a   Kojima, A ^a   Takezawa, J ^a   Suzuki, K ^a   Sato, S ^a   Mori, M ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Genotype Ib; Hepatitis C virus; High virus load; Interferon; Zinc

Indexed keywords

AMINOTRANSFERASE; INTERFERON; LIVER ENZYME; PLOMAC; POLAPREZINC; VIRUS RNA; ZINC;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; ERYTHEMA MULTIFORME; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GENOTYPE; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INSOMNIA; INTERSTITIAL PNEUMONIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNCONSCIOUSNESS; VIRUS LOAD;

ADULT; CARNOSINE; DNA, VIRAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TREATMENT OUTCOME; VIRAL LOAD; ZINC;

EID: 0035724958     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2001.00311.x     Document Type: Article

References (26)

1. Twice daily treatment of interferon β for hepatitis C
2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
3. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials
4. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: A randomized, controlled trial
5. N-Acetyl cystein enhances the response to interferon-alfa in chronic hepatitis C: A pilot study
6. Prediction of the effect of interferon on chronic hepatitis C
7. Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: An Italian multicenter study on dose and duration of IFN alpha treatment
8. Trace element and chronic liver diseases
9. Severe zinc deficiency
10. Zinc supplementation and stunted infants in Ethiopia: A randomised controlled trial
11. Inhibition of HIV-1 infection by zinc group metal compounds
12. Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants
13. Therapy of banal HSV lesions: Molecular mechanisms of the antiviral activity of zinc sulfate
14. The antioxidant properties of zinc
15. Zinc and immunity
16. Preliminary study of combination therapy with IFN and zinc in chronic hepatitis C patients with genotype Ib
17. A classification of chronic hepatitis
18. Determination of serum zinc by atomic absorption spectrometry
19. The possible role of zinc and metallothionein in the liver on the therapeutic effects of IFN- in hepatitis C patients
20. Effects of zinc-L-carnosine on gastric mucosal cell damage caused by ethanol in rats
21. Clinical evaluation of Z-103 in the treatment of gastric ulcer
22. Study on the metabolic fate of catena-(s)-(m(Na-3-aminopropionyl)histidinate(2-)-N1, N2, O:N)-zinc
23. Zinc and immune function: The biological basis of altered resistance to infection
24. Zinc and immuno-resistance to infection in aging: New biological tools
25. Role of etallothionein in zinc and chromium mediated tolerance to carbon tetrachloride hepatotoxicity: Evidence against a trichloromethyl radical scavenging mechanism
26. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography